# Lenalidomide Monotherapy in R/R DLBCL

> **NCT04150328** · — · COMPLETED · sponsor: **MorphoSys AG** · enrollment: 490 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04150328
- **Lead sponsor:** MorphoSys AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2019-08-25
- **Final completion:** 2020-08-25
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2022-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150328, "Lenalidomide Monotherapy in R/R DLBCL". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04150328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*